| Dabur Oncology Plc, the UK-based wholly-owned subsidiary of Dabur Pharma, has been granted approval for Carboplatin molecule by the USFDA on September 29, 2006. This was announced in a release issued by Dabur Pharma to the BSE today. |
Dabur Pharma gets USFDA nod for Carboplatin
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Oct 03 2006 | 11:15 AM IST
